<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Bridging for Drug-Device and Biologic-Device Combination Products; Draft Guidance for Industry; Availability; Extension of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Bridging for Drug-Device and Biologic-Device Combination Products; Draft Guidance for Industry; Availability; Extension of Comment Period</h1>
    <p class="timestamp">Published: 2020-02-14 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of December 19, 2019. In the notice of availability, FDA requested comments on the draft guidance for industry entitled "Bridging for Drug-Device and Biologic-Device Combination Products." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-03023</p>
    <p><strong>Publication Date:</strong> 2020-02-14</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/02/14/2020-03023/bridging-for-drug-device-and-biologic-device-combination-products-draft-guidance-for-industry">https://www.federalregister.gov/documents/2020/02/14/2020-03023/bridging-for-drug-device-and-biologic-device-combination-products-draft-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-03023</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
